Trials / Recruiting
RecruitingNCT06200558
ARON-3 Study: International Multicentric Retrospective Study to Collect Global Experiences in the Treatment of Patients With Metastatic PCa
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 534 (estimated)
- Sponsor
- Hospital of Macerata · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study wants to explore real-world data in three distinct settings * Patients with metachronous or de novo mCSPC treated with ADT+ARSI or ADT+ARSI+docetaxel \_ARON-3S * Patients receiving Lutetium-177 PSMA for mCRPC \_ ARON-3Lu * Patients treated with PARP inhibitors (alone or combined with ARSI) for CRPC \_ ARON-3GEN
Conditions
Timeline
- Start date
- 2024-01-31
- Primary completion
- 2024-05-31
- Completion
- 2028-02-01
- First posted
- 2024-01-11
- Last updated
- 2025-11-26
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06200558. Inclusion in this directory is not an endorsement.